Archives

by in
Entry Author Date Location
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone 03/18/14 Boston
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal 03/17/14 San Francisco
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Juno Therapeutics Adds Jeff Bezos, Venrock to $145M Venture Deal 01/13/14 Seattle
Blueprint Medicines Hauls in $25M For Cancer Drug Push 01/07/14 Boston
A Revolution is Taking Place in the Treatment of Blood Cancers 12/16/13 National
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Ariad Pulls Cancer Drug Off the Market as Trial Fallout Continues 10/31/13 Boston
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet 10/09/13 Boston
Boston’s Life Science Disruptors: The Photos 10/07/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug 09/03/13 Boston
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Page 1 of 12 next page »